Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helma Freitag

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Plos One|March 16, 2018
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/MECarmen Scheibenbogen, Madlen Loebel, Helma Freitag, et al.
Journal of Clinical Medicine|April 13, 2024
Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue SyndromeAnna Paffrath, Laura Kim, Claudia Kedor, et al.
Frontiers in Immunology|April 23, 2021
Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue SyndromeMarvin Szklarski, Helma Freitag, Sebastian Lorenz, et al.
Heliyon|August 3, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression dataJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studiesJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Journal of Translational Medicine|March 23, 2022
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)Milan Haffke, Helma Freitag, Gordon Rudolf, et al.
Journal of Translational Medicine|July 28, 2017
The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENECarmen Scheibenbogen, Helma Freitag, Julià Blanco, et al.
Oncotarget|March 24, 2015
FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumorsFranziska Briest, Erika Berg, Irina Grass, et al.
Brain, Behavior, & Immunity - Health|November 24, 2025
Functional olfactory impairment and fatigue in post-COVID-19 syndrome including ME/CFS - a longitudinal prospective observational studyLil Meyer-Arndt, Greta Pierchalla, Lukas Mödl, et al.
Eclinicalmedicine|September 4, 2023
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohortFranziska Legler, Lil Meyer-Arndt, Lukas Mödl, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|March 16, 2018
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/MECarmen Scheibenbogen, Madlen Loebel, Helma Freitag, et al.
Journal of Clinical Medicine|April 13, 2024
Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue SyndromeAnna Paffrath, Laura Kim, Claudia Kedor, et al.
Frontiers in Immunology|April 23, 2021
Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue SyndromeMarvin Szklarski, Helma Freitag, Sebastian Lorenz, et al.
Heliyon|August 3, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome: A meta-analysis of public DNA methylation and gene expression dataJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studiesJoão Malato, Franziska Sotzny, Sandra Bauer, et al.
Journal of Translational Medicine|March 23, 2022
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)Milan Haffke, Helma Freitag, Gordon Rudolf, et al.
Journal of Translational Medicine|July 28, 2017
The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENECarmen Scheibenbogen, Helma Freitag, Julià Blanco, et al.
Oncotarget|March 24, 2015
FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumorsFranziska Briest, Erika Berg, Irina Grass, et al.
Brain, Behavior, & Immunity - Health|November 24, 2025
Functional olfactory impairment and fatigue in post-COVID-19 syndrome including ME/CFS - a longitudinal prospective observational studyLil Meyer-Arndt, Greta Pierchalla, Lukas Mödl, et al.
Eclinicalmedicine|September 4, 2023
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohortFranziska Legler, Lil Meyer-Arndt, Lukas Mödl, et al.
Pageof 3